The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erythromycin Market Research Report 2025
Synopsis
Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.
The global Erythromycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Erythromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erythromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Erythromycin include Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P and Alembic Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Erythromycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin.
Report Scope
The Erythromycin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erythromycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma
Segment by Type
Erythromycin Thiocyanate
Azithromycin
Clarithromycin
Roxithromycin
Others
Segment by Application
Human Medication
Veterinary Medication
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Erythromycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Erythromycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.
The global Erythromycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Erythromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erythromycin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Erythromycin include Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P and Alembic Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Erythromycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin.
Report Scope
The Erythromycin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erythromycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma
Segment by Type
Erythromycin Thiocyanate
Azithromycin
Clarithromycin
Roxithromycin
Others
Segment by Application
Human Medication
Veterinary Medication
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Erythromycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Erythromycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Erythromycin Market Overview
1.1 Product Definition
1.2 Erythromycin Segment by Type
1.2.1 Global Erythromycin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Erythromycin Thiocyanate
1.2.3 Azithromycin
1.2.4 Clarithromycin
1.2.5 Roxithromycin
1.2.6 Others
1.3 Erythromycin Segment by Application
1.3.1 Global Erythromycin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Human Medication
1.3.3 Veterinary Medication
1.4 Global Market Growth Prospects
1.4.1 Global Erythromycin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Erythromycin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Erythromycin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Erythromycin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Erythromycin Production Market Share by Manufacturers (2019-2024)
2.2 Global Erythromycin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Erythromycin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Erythromycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Erythromycin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Erythromycin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Erythromycin, Product Offered and Application
2.8 Global Key Manufacturers of Erythromycin, Date of Enter into This Industry
2.9 Erythromycin Market Competitive Situation and Trends
2.9.1 Erythromycin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Erythromycin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Erythromycin Production by Region
3.1 Global Erythromycin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Erythromycin Production Value by Region (2019-2030)
3.2.1 Global Erythromycin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Erythromycin by Region (2025-2030)
3.3 Global Erythromycin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Erythromycin Production by Region (2019-2030)
3.4.1 Global Erythromycin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Erythromycin by Region (2025-2030)
3.5 Global Erythromycin Market Price Analysis by Region (2019-2024)
3.6 Global Erythromycin Production and Value, Year-over-Year Growth
3.6.1 North America Erythromycin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Erythromycin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Erythromycin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Erythromycin Production Value Estimates and Forecasts (2019-2030)
4 Erythromycin Consumption by Region
4.1 Global Erythromycin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Erythromycin Consumption by Region (2019-2030)
4.2.1 Global Erythromycin Consumption by Region (2019-2024)
4.2.2 Global Erythromycin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Erythromycin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Erythromycin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Erythromycin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Erythromycin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Erythromycin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Erythromycin Production by Type (2019-2030)
5.1.1 Global Erythromycin Production by Type (2019-2024)
5.1.2 Global Erythromycin Production by Type (2025-2030)
5.1.3 Global Erythromycin Production Market Share by Type (2019-2030)
5.2 Global Erythromycin Production Value by Type (2019-2030)
5.2.1 Global Erythromycin Production Value by Type (2019-2024)
5.2.2 Global Erythromycin Production Value by Type (2025-2030)
5.2.3 Global Erythromycin Production Value Market Share by Type (2019-2030)
5.3 Global Erythromycin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Erythromycin Production by Application (2019-2030)
6.1.1 Global Erythromycin Production by Application (2019-2024)
6.1.2 Global Erythromycin Production by Application (2025-2030)
6.1.3 Global Erythromycin Production Market Share by Application (2019-2030)
6.2 Global Erythromycin Production Value by Application (2019-2030)
6.2.1 Global Erythromycin Production Value by Application (2019-2024)
6.2.2 Global Erythromycin Production Value by Application (2025-2030)
6.2.3 Global Erythromycin Production Value Market Share by Application (2019-2030)
6.3 Global Erythromycin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Kelun Chuanning Biotechnology
7.1.1 Kelun Chuanning Biotechnology Erythromycin Corporation Information
7.1.2 Kelun Chuanning Biotechnology Erythromycin Product Portfolio
7.1.3 Kelun Chuanning Biotechnology Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Kelun Chuanning Biotechnology Main Business and Markets Served
7.1.5 Kelun Chuanning Biotechnology Recent Developments/Updates
7.2 Ercros S.A.
7.2.1 Ercros S.A. Erythromycin Corporation Information
7.2.2 Ercros S.A. Erythromycin Product Portfolio
7.2.3 Ercros S.A. Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Ercros S.A. Main Business and Markets Served
7.2.5 Ercros S.A. Recent Developments/Updates
7.3 HEC Group
7.3.1 HEC Group Erythromycin Corporation Information
7.3.2 HEC Group Erythromycin Product Portfolio
7.3.3 HEC Group Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 HEC Group Main Business and Markets Served
7.3.5 HEC Group Recent Developments/Updates
7.4 Envee Drugs Pvt Ltd
7.4.1 Envee Drugs Pvt Ltd Erythromycin Corporation Information
7.4.2 Envee Drugs Pvt Ltd Erythromycin Product Portfolio
7.4.3 Envee Drugs Pvt Ltd Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Envee Drugs Pvt Ltd Main Business and Markets Served
7.4.5 Envee Drugs Pvt Ltd Recent Developments/Updates
7.5 Mehta Api
7.5.1 Mehta Api Erythromycin Corporation Information
7.5.2 Mehta Api Erythromycin Product Portfolio
7.5.3 Mehta Api Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Mehta Api Main Business and Markets Served
7.5.5 Mehta Api Recent Developments/Updates
7.6 Abbvie
7.6.1 Abbvie Erythromycin Corporation Information
7.6.2 Abbvie Erythromycin Product Portfolio
7.6.3 Abbvie Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Abbvie Main Business and Markets Served
7.6.5 Abbvie Recent Developments/Updates
7.7 Ningxia Qiyuan
7.7.1 Ningxia Qiyuan Erythromycin Corporation Information
7.7.2 Ningxia Qiyuan Erythromycin Product Portfolio
7.7.3 Ningxia Qiyuan Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Ningxia Qiyuan Main Business and Markets Served
7.7.5 Ningxia Qiyuan Recent Developments/Updates
7.8 Calyx C & P
7.8.1 Calyx C & P Erythromycin Corporation Information
7.8.2 Calyx C & P Erythromycin Product Portfolio
7.8.3 Calyx C & P Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Calyx C & P Main Business and Markets Served
7.7.5 Calyx C & P Recent Developments/Updates
7.9 Alembic Pharma
7.9.1 Alembic Pharma Erythromycin Corporation Information
7.9.2 Alembic Pharma Erythromycin Product Portfolio
7.9.3 Alembic Pharma Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Alembic Pharma Main Business and Markets Served
7.9.5 Alembic Pharma Recent Developments/Updates
7.10 SM Biomed
7.10.1 SM Biomed Erythromycin Corporation Information
7.10.2 SM Biomed Erythromycin Product Portfolio
7.10.3 SM Biomed Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.10.4 SM Biomed Main Business and Markets Served
7.10.5 SM Biomed Recent Developments/Updates
7.11 Anuh Pharma
7.11.1 Anuh Pharma Erythromycin Corporation Information
7.11.2 Anuh Pharma Erythromycin Product Portfolio
7.11.3 Anuh Pharma Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Anuh Pharma Main Business and Markets Served
7.11.5 Anuh Pharma Recent Developments/Updates
7.12 Shaoxing Hantai Pharma
7.12.1 Shaoxing Hantai Pharma Erythromycin Corporation Information
7.12.2 Shaoxing Hantai Pharma Erythromycin Product Portfolio
7.12.3 Shaoxing Hantai Pharma Erythromycin Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Shaoxing Hantai Pharma Main Business and Markets Served
7.12.5 Shaoxing Hantai Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Erythromycin Industry Chain Analysis
8.2 Erythromycin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Erythromycin Production Mode & Process
8.4 Erythromycin Sales and Marketing
8.4.1 Erythromycin Sales Channels
8.4.2 Erythromycin Distributors
8.5 Erythromycin Customers
9 Erythromycin Market Dynamics
9.1 Erythromycin Industry Trends
9.2 Erythromycin Market Drivers
9.3 Erythromycin Market Challenges
9.4 Erythromycin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Erythromycin Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Erythromycin Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Erythromycin Production Capacity (MT) by Manufacturers in 2023
Table 4. Global Erythromycin Production by Manufacturers (2019-2024) & (MT)
Table 5. Global Erythromycin Production Market Share by Manufacturers (2019-2024)
Table 6. Global Erythromycin Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Erythromycin Production Value Share by Manufacturers (2019-2024)
Table 8. Global Erythromycin Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythromycin as of 2023)
Table 10. Global Market Erythromycin Average Price by Manufacturers (USD/Kg) & (2019-2024)
Table 11. Manufacturers Erythromycin Production Sites and Area Served
Table 12. Manufacturers Erythromycin Product Types
Table 13. Global Erythromycin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Erythromycin Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Erythromycin Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Erythromycin Production Value Market Share by Region (2019-2024)
Table 18. Global Erythromycin Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Erythromycin Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Erythromycin Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)
Table 21. Global Erythromycin Production (MT) by Region (2019-2024)
Table 22. Global Erythromycin Production Market Share by Region (2019-2024)
Table 23. Global Erythromycin Production (MT) Forecast by Region (2025-2030)
Table 24. Global Erythromycin Production Market Share Forecast by Region (2025-2030)
Table 25. Global Erythromycin Market Average Price (USD/Kg) by Region (2019-2024)
Table 26. Global Erythromycin Market Average Price (USD/Kg) by Region (2025-2030)
Table 27. Global Erythromycin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)
Table 28. Global Erythromycin Consumption by Region (2019-2024) & (MT)
Table 29. Global Erythromycin Consumption Market Share by Region (2019-2024)
Table 30. Global Erythromycin Forecasted Consumption by Region (2025-2030) & (MT)
Table 31. Global Erythromycin Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 33. North America Erythromycin Consumption by Country (2019-2024) & (MT)
Table 34. North America Erythromycin Consumption by Country (2025-2030) & (MT)
Table 35. Europe Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 36. Europe Erythromycin Consumption by Country (2019-2024) & (MT)
Table 37. Europe Erythromycin Consumption by Country (2025-2030) & (MT)
Table 38. Asia Pacific Erythromycin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)
Table 39. Asia Pacific Erythromycin Consumption by Region (2019-2024) & (MT)
Table 40. Asia Pacific Erythromycin Consumption by Region (2025-2030) & (MT)
Table 41. Latin America, Middle East & Africa Erythromycin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 42. Latin America, Middle East & Africa Erythromycin Consumption by Country (2019-2024) & (MT)
Table 43. Latin America, Middle East & Africa Erythromycin Consumption by Country (2025-2030) & (MT)
Table 44. Global Erythromycin Production (MT) by Type (2019-2024)
Table 45. Global Erythromycin Production (MT) by Type (2025-2030)
Table 46. Global Erythromycin Production Market Share by Type (2019-2024)
Table 47. Global Erythromycin Production Market Share by Type (2025-2030)
Table 48. Global Erythromycin Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Erythromycin Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Erythromycin Production Value Share by Type (2019-2024)
Table 51. Global Erythromycin Production Value Share by Type (2025-2030)
Table 52. Global Erythromycin Price (USD/Kg) by Type (2019-2024)
Table 53. Global Erythromycin Price (USD/Kg) by Type (2025-2030)
Table 54. Global Erythromycin Production (MT) by Application (2019-2024)
Table 55. Global Erythromycin Production (MT) by Application (2025-2030)
Table 56. Global Erythromycin Production Market Share by Application (2019-2024)
Table 57. Global Erythromycin Production Market Share by Application (2025-2030)
Table 58. Global Erythromycin Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Erythromycin Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Erythromycin Production Value Share by Application (2019-2024)
Table 61. Global Erythromycin Production Value Share by Application (2025-2030)
Table 62. Global Erythromycin Price (USD/Kg) by Application (2019-2024)
Table 63. Global Erythromycin Price (USD/Kg) by Application (2025-2030)
Table 64. Kelun Chuanning Biotechnology Erythromycin Corporation Information
Table 65. Kelun Chuanning Biotechnology Specification and Application
Table 66. Kelun Chuanning Biotechnology Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 67. Kelun Chuanning Biotechnology Main Business and Markets Served
Table 68. Kelun Chuanning Biotechnology Recent Developments/Updates
Table 69. Ercros S.A. Erythromycin Corporation Information
Table 70. Ercros S.A. Specification and Application
Table 71. Ercros S.A. Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 72. Ercros S.A. Main Business and Markets Served
Table 73. Ercros S.A. Recent Developments/Updates
Table 74. HEC Group Erythromycin Corporation Information
Table 75. HEC Group Specification and Application
Table 76. HEC Group Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 77. HEC Group Main Business and Markets Served
Table 78. HEC Group Recent Developments/Updates
Table 79. Envee Drugs Pvt Ltd Erythromycin Corporation Information
Table 80. Envee Drugs Pvt Ltd Specification and Application
Table 81. Envee Drugs Pvt Ltd Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 82. Envee Drugs Pvt Ltd Main Business and Markets Served
Table 83. Envee Drugs Pvt Ltd Recent Developments/Updates
Table 84. Mehta Api Erythromycin Corporation Information
Table 85. Mehta Api Specification and Application
Table 86. Mehta Api Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 87. Mehta Api Main Business and Markets Served
Table 88. Mehta Api Recent Developments/Updates
Table 89. Abbvie Erythromycin Corporation Information
Table 90. Abbvie Specification and Application
Table 91. Abbvie Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 92. Abbvie Main Business and Markets Served
Table 93. Abbvie Recent Developments/Updates
Table 94. Ningxia Qiyuan Erythromycin Corporation Information
Table 95. Ningxia Qiyuan Specification and Application
Table 96. Ningxia Qiyuan Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 97. Ningxia Qiyuan Main Business and Markets Served
Table 98. Ningxia Qiyuan Recent Developments/Updates
Table 99. Calyx C & P Erythromycin Corporation Information
Table 100. Calyx C & P Specification and Application
Table 101. Calyx C & P Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 102. Calyx C & P Main Business and Markets Served
Table 103. Calyx C & P Recent Developments/Updates
Table 104. Alembic Pharma Erythromycin Corporation Information
Table 105. Alembic Pharma Specification and Application
Table 106. Alembic Pharma Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 107. Alembic Pharma Main Business and Markets Served
Table 108. Alembic Pharma Recent Developments/Updates
Table 109. SM Biomed Erythromycin Corporation Information
Table 110. SM Biomed Specification and Application
Table 111. SM Biomed Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 112. SM Biomed Main Business and Markets Served
Table 113. SM Biomed Recent Developments/Updates
Table 114. Anuh Pharma Erythromycin Corporation Information
Table 115. Anuh Pharma Specification and Application
Table 116. Anuh Pharma Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 117. Anuh Pharma Main Business and Markets Served
Table 118. Anuh Pharma Recent Developments/Updates
Table 119. Shaoxing Hantai Pharma Erythromycin Corporation Information
Table 120. Shaoxing Hantai Pharma Specification and Application
Table 121. Shaoxing Hantai Pharma Erythromycin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 122. Shaoxing Hantai Pharma Main Business and Markets Served
Table 123. Shaoxing Hantai Pharma Recent Developments/Updates
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Erythromycin Distributors List
Table 127. Erythromycin Customers List
Table 128. Erythromycin Market Trends
Table 129. Erythromycin Market Drivers
Table 130. Erythromycin Market Challenges
Table 131. Erythromycin Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Erythromycin
Figure 2. Global Erythromycin Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Erythromycin Market Share by Type: 2023 VS 2030
Figure 4. Erythromycin Thiocyanate Product Picture
Figure 5. Azithromycin Product Picture
Figure 6. Clarithromycin Product Picture
Figure 7. Roxithromycin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Erythromycin Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global Erythromycin Market Share by Application: 2023 VS 2030
Figure 11. Human Medication
Figure 12. Veterinary Medication
Figure 13. Global Erythromycin Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Erythromycin Production Value (US$ Million) & (2019-2030)
Figure 15. Global Erythromycin Production Capacity (MT) & (2019-2030)
Figure 16. Global Erythromycin Production (MT) & (2019-2030)
Figure 17. Global Erythromycin Average Price (USD/Kg) & (2019-2030)
Figure 18. Erythromycin Report Years Considered
Figure 19. Erythromycin Production Share by Manufacturers in 2023
Figure 20. Erythromycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. The Global 5 and 10 Largest Players: Market Share by Erythromycin Revenue in 2023
Figure 22. Global Erythromycin Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 23. Global Erythromycin Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. Global Erythromycin Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)
Figure 25. Global Erythromycin Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 26. North America Erythromycin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Europe Erythromycin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. China Erythromycin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Japan Erythromycin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 30. Global Erythromycin Consumption by Region: 2019 VS 2023 VS 2030 (MT)
Figure 31. Global Erythromycin Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 32. North America Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 33. North America Erythromycin Consumption Market Share by Country (2019-2030)
Figure 34. Canada Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 35. U.S. Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 36. Europe Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 37. Europe Erythromycin Consumption Market Share by Country (2019-2030)
Figure 38. Germany Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 39. France Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 40. U.K. Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 41. Italy Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 42. Russia Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 43. Asia Pacific Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 44. Asia Pacific Erythromycin Consumption Market Share by Regions (2019-2030)
Figure 45. China Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 46. Japan Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 47. South Korea Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 48. China Taiwan Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 49. Southeast Asia Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 50. India Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 51. Latin America, Middle East & Africa Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 52. Latin America, Middle East & Africa Erythromycin Consumption Market Share by Country (2019-2030)
Figure 53. Mexico Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 54. Brazil Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 55. Turkey Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 56. GCC Countries Erythromycin Consumption and Growth Rate (2019-2024) & (MT)
Figure 57. Global Production Market Share of Erythromycin by Type (2019-2030)
Figure 58. Global Production Value Market Share of Erythromycin by Type (2019-2030)
Figure 59. Global Erythromycin Price (USD/Kg) by Type (2019-2030)
Figure 60. Global Production Market Share of Erythromycin by Application (2019-2030)
Figure 61. Global Production Value Market Share of Erythromycin by Application (2019-2030)
Figure 62. Global Erythromycin Price (USD/Kg) by Application (2019-2030)
Figure 63. Erythromycin Value Chain
Figure 64. Erythromycin Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
